These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Clinical experiences with the cutaneous applications of hydrogen peroxide in obstetrics]. Felker A, Rothe K. Dtsch Gesundheitsw; 1967 Jun 15; 22(24):1119-24. PubMed ID: 5601580 [No Abstract] [Full Text] [Related]
28. [Contribution to the treatment of venous disease. Gas plethysmography study of a new vaso-active drug]. Kissel P, Royer R. Therapeutique; 1970 Nov 15; 46(9):907-9. PubMed ID: 5486140 [No Abstract] [Full Text] [Related]
30. [The use of oxyphenyl-oxy-butylaminoethane in pregnant women]. Simões NP. Rev Bras Med; 1965 May 15; 22(5):308-9. PubMed ID: 4378846 [No Abstract] [Full Text] [Related]
34. [Value of the use of Ercevit P as an adjuvant in the surgical treatment of varicose veins of the lower limbs and in hemorrhoids]. Roghi T, Coulibeuf J. Phlebologie; 1970 May 15; 23(4):365-75. PubMed ID: 4993146 [No Abstract] [Full Text] [Related]
35. [Clinical studies of Ercevit fort (author's transl)]. Aoun R. Sem Hop; 1970 May 15; 54(37-40):1189-90. PubMed ID: 217103 [No Abstract] [Full Text] [Related]
36. [Subcutaneous varicose veins in relation to the localization of placenta]. Lyzyn MA, Vasiliuk MD, Lanovoĭ ID, Loza VA. Sov Med; 1984 May 15; (10):22-5. PubMed ID: 6515442 [No Abstract] [Full Text] [Related]
37. [Plethysmographic and pharmacokinetic study of a venotropic drug: disodium flavodate]. Schmidt C, Demange G, Kohler F, Nabet-Belleville F, Royer RJ, Schmitt J. Therapie; 1985 May 15; 40(4):221-4. PubMed ID: 4024016 [No Abstract] [Full Text] [Related]
38. [What can the physician expect from "venotropic" drugs?]. Stemmer R. Phlebologie; 1970 May 15; 23(3):251-63. PubMed ID: 5475591 [No Abstract] [Full Text] [Related]